AS
Ascendis Pharma
ASND·NASDAQCopenhagen DKFounded 2007800 employees
Mid CapbiotechPublicRare DiseaseEndocrinology
Platform: TransCon
Market Cap
$8B
All Drugs
4
Clinical Trials
8
Failed / Terminated
3
FDA Approved
0
Stock Price & Catalysts (ASND)
Loading ASND stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ASN-7038 | ASN-7038 | Phase 3 | 2 | VEGF | CSUBladder Ca | ||
| ASN-4879 | ASN-4879 | Phase 3 | 4 | CGRP | PSPPompe | ||
| Tezelucimab | ASN-4195 | Preclinical | 1 | SHP2 | SMA | ||
| ASN-7408 | ASN-7408 | NDA/BLA | 1 | GPRC5D | PSP |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (7)